Day One Biopharmaceuticals Inc (DAWN) Stock Analysis

Day One Biopharmaceuticals Inc (DAWN) is a publicly traded company in the HEALTHCARE sector. It trades at $21.53. This page summarizes the public market data, fundamentals, and frequently asked questions for DAWN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $21.53

Market Sentiment

Day One Biopharmaceuticals Inc currently has a Bullish sentiment score of 0.75.

About Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing targeted therapies for genetically defined cancers. The company is distinguished by its robust pipeline of treatments designed to address significant unmet medical needs in oncology, employing precision medicine to enhance patient outcomes. By leveraging innovative scientific approaches that specifically target genetic mutations present in tu...

GNG Research Analysis

GNG Research scores Day One Biopharmaceuticals Inc (DAWN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DAWN.

Frequently Asked Questions

Does DAWN pay dividends?

Day One Biopharmaceuticals Inc (DAWN) does not currently pay a regular dividend.